ABSTRACT: Indolotryptolines are bisindole natural products 8 isolated from microbial and eDNA sources. Here, we report 9 the sequence of transformations that convert an indolocarba-10 zole to the indolotryptoline cladoniamide through reconstruc- The more common indolocarbazole natural products are 44 known to derive from the oxidative dimerization of L-45 tryptophan derivatives through a four-enzyme cascade that 46 funnels substrates toward indolocarbazole aglycones.
highlights the importance of nonenzymatic chemistry in generating bisindole diversity. 19 A unique group of bacterially derived alkaloids are bisindoles, 20 molecules derived from the oxidative dimerization of L-21 tryptophan.
1 Among bisindoles, indolocarbazoles are the most 22 frequently reported structures from bacteria and include 23 examples such as rebeccamycin and staurosporine. 2 Other, 24 nonindolocarbazole bisindoles include indolotryptolines, which 25 have a rearranged bisindole core. Cladoniamides A−G (1−7), 26 isolated from a Streptomyces strain, were the first indolotrypto-27 lines to be reported with structural information. 3 Screening of 28 environmental DNA libraries for chromopyrrolic acid synthase 29 genes has also resulted in identification of gene clusters that 30 when heterologously expressed generate indolotryptolines BE-31 54017 (8) 4 and borregomycin A (9), 5 giving a total of three f1 32 small families of natural indolotryptolines ( Figure 1 ). 33 Cladoniamides A and B are nanomolar cytotoxic agents against 34 colon cancer cell line HCT-116, 4,6 whereas cladoniamide G is 35 the active lead analogue against breast cancer cell line MCF-7.
3 36 In vitro studies of BE-54017 show that the compound induces 37 apoptosis in cells overexpressing epidermal growth factor 38 receptor (EGFR), possibly through inhibition of the vacuolar-39 type H + -ATPase. 7 Borregomycin A, by contrast, appears to be a 40 specific inhibitor of kinase CaMKIIδ with an IC 50 of 3.4 μM. The more common indolocarbazole natural products are 44 known to derive from the oxidative dimerization of L-45 tryptophan derivatives through a four-enzyme cascade that 46 funnels substrates toward indolocarbazole aglycones.
2 Early on, 47 with the discovery of the indolotryptoline cladoniamide, it was 48 hypothesized that the rare indolotryptoline molecules might 49 derive from more common indolocarbazole aglycones. ORTEP-style image of compound 10, drawn with 33% probability ellipses. All C−H hydrogen atoms were removed for clarity.
103 lated products was unknown. We thus generated strain S. 104 coelicolor YD52, which has an engineered cla cluster whose 105 claM1 gene was in-frame deleted (Supporting Information (SI) 106 Figure S1 ). Large-scale (12 L) fermentation of S. coelicolor 107 YD52 was performed, and a series of bisindoles were purified 108 from the extract of its culture and characterized based on MS Table S3 and Figure S8 ). Table S10 ).
131
To provide more direct evidence for the transformations 132 catalyzed by cladoniamide enzymes, we sought to reconstruct 133 the cladoniamide pathway in E. coli using synthetic 134 indolocarbazole precursors. We undertook a heterologous 135 biotransformation approach, rather than an in vitro approach, 136 as all efforts to access soluble ClaX1 and ClaX2, including 137 testing of their codon-optimized homologues AbeX1 and 138 AbeX2, were unsuccessful. We reasoned that arcyriaflavin A 139 (21), a commercially available, nonchlorinated indolocarbazole, 140 would be a direct substrate for the first enzyme, ClaX1, based 141 on the production of nonchlorinated metabolites from both cla 142 and abe pathways. We thus fed 21 to the E. coli culture 143 expressing claX1. HPLC analysis revealed the production of 144 two new metabolites, both of which are also produced when E. 145 coli/claX1 is replaced with E. coli/abeX1. As parallel controls, no 146 products were detected when arcyriaflavin A was provided to E. 147 coli strains containing empty vector or claX2 (SI Figure S3a) . 148 These two metabolites were identified to be 12 and 15 by 149 comparison with standard compounds purified from the claM1 150 deletion mutant. Observation of the indolo-oxazino-carbazole 151 15 from this biotransformation assay was unexpected. To 152 investigate whether 15 is direct product of ClaX1-catalyzed 153 reaction or instead a decomposed product of 12, we repeated 154 the feeding experiment and analyzed the culture extract at 155 different time points. The result showed the accumulation of 156 large amount of 15 only after longer incubations (12 h) (SI 157 Figure S3b ), suggesting that 15 might derive from 12.
158
To probe the next step in construction of cladoniamide, an in 159 vitro biochemical assay of ClaM1 was performed. ClaM1 was 160 purified as a C-terminal His 6 -tagged protein from E. Figure S4) . Additionally, a small amount of 167 15 formed in all the control and experimental assays, suggesting 168 that 12 partially converted to 15 under the condition we used. 169 No product was observed when we used 21 as a substrate in 170 this assay, confirming that the ClaM1-catalyzed N-methylation 171 occurs after the ClaX1-catalyzed oxidation. Interestingly, 15 can 172 also be accepted as a substrate by ClaM1 and gives a new 173 product. This compound was isolated from a large-scale ClaM1 174 reaction and confirmed to be the N-methylated indolo-oxazino-175 carbazole 23 by 1D and 2D NMR (SI Figure S14 and Tables  176 S7−S8) .
177
To investigate the role of ClaX2, three genes (abeX1, claM1 178 and claX2) were cloned and assembled in two compatible E. coli 179 vectors for coexpression with all the genes behind the T7 180 promoter. Since the work described above showed that ClaX1 181 and AbeX1 are functionally equivalent, we used abeX1 to .4 for S. albus + cla, and the pH is ∼7.9 for S. coelicolor + cla. 246 The S. coelicolor + cla strain is known to produce more minor 247 cladoniamides, 6 suggesting that an increase in pH might explain 248 the observed differences in metabolic profile. Thus, pure 249 cladoniamide A (1) and B (2) were added to buffered aqueous 250 solutions (pH 8.0). After 24 h of incubation, cladoniamides D/ 251 F (4/6) and E/G (5/7) were detected from the solution of 7), respectively. HPLC trace of (i) the crude extract of the S. coelicolor host carrying cla cluster, which produces 1, 2, 4, 5, 6, and 7, 6 (ii) incubation of 1 in pure H 2 O for 24 h, (iii) incubation of 1 in 25 mM Tris-HCl buffer (pH 8.0) for 24 h, (iv) incubation of 2 in pure H 2 O for 24 h, (v) incubation of267 indolotryptoline structure itself. Furthermore, we gained some 268 mechanistic insight into the function of ClaX1 from analysis of 269 10, purified from the ΔclaM1 strain. Compound 10, which is 270 also a product of ClaX1 catalysis, has its hydroxyls in a cis 271 configuration, in contrast to what would be expected for 272 hydrolysis of an epoxide through an S N 2-type mechanism. One 273 scenario to account for the biogenesis of 10 is that ClaX1, a 274 putative flavin monooxygenase, epoxidizes the C4c/C7a double 275 bond of the indolocarbazole. Spontaneous ring-opening of a 276 protonated epoxide would then generate a resonance-stabilized 277 carbocation at either the C4c or C7a carbon, which would then 278 be attacked by water. One possible explanation for the 279 formation of a cis diol, rather than a trans diol, is that the 280 corresponding trans fused 5,6 ring system is strained and 281 therefore less stable. Similarly, trans diol formation through an 282 S N 2-type opening of an epoxide is likely disfavored due to 283 formation of a strained trans fused 5,6 ring system. The exact 284 function of ClaX2 is less clear. However, our data now 285 demonstrate that ClaX2, alone, can catalyze the "flipping" of 286 the indole ring to give the indolotryptoline scaffold. Based on 287 the annotation of ClaX2 as a flavin monooxygenase, the 288 mechanism is likely to involve a key epoxidation (or 289 hydroxylation) across the C7b/C12b double bond of the N-290 methylated indolocarbazole diol, priming the molecule for a 291 spontaneous rearrangement.
3 The inability to purify either 292 soluble ClaX1 or ClaX2 has hampered detailed in vitro studies 293 of these enzymes; nonetheless, our heterologous biotransfor-294 mation is the first unequivocal demonstration of the activity of 295 these enzymes in the indolotryptoline pathway. The authors declare no competing financial interest. Lett. 14, 4418−21. e23694.
